Literature DB >> 29614249

Elavl3 regulates neuronal polarity through the alternative splicing of an embryo-specific exon in AnkyrinG.

Yuki Ogawa1, Junji Yamaguchi2, Masato Yano3, Yasuo Uchiyama2, Hirotaka James Okano4.   

Abstract

Alternative splicing of RNAs diversifies the functionalities of proteins, and it is optimized for each cell type and each developmental stage. nElavl (composed of Elavl2, Elavl3, and Elavl4) proteins are the RNA-binding proteins that is specifically expressed in neurons, regulate the alternative splicing of target RNAs, and promote neuronal differentiation and maturation. Recent studies revealed that Elavl3 knockout (Elavl3-/-) mice completely lost the expression of nElavl proteins in the Purkinje cells and exhibited cerebellar dysfunction. Here, we found that the alternative splicing of AnkyrinG exon 34 was misregulated in the cerebella of Elavl3-/- mice. AnkyrinG is an essential factor for the formation of neuronal polarity and is required for normal neuronal functions. We revealed that exon 34 of AnkyrinG was normally included in immature neurons and was mostly excluded in mature neurons; however, it was included in the cerebella of Elavl3-/- mice even in adulthood. In the Purkinje cells of adult Elavl3-/- mice, the length of the AnkyrinG-positive region shortened and somatic organelles leaked into the axons. These results suggested that exon 34 of AnkyrinG is an embryonic-stage-preferential exon that should be excluded from mature neurons and that Elavl3 regulates neuronal polarity through alternative splicing of this exon.
Copyright © 2018 Elsevier B.V. and Japan Neuroscience Society. All rights reserved.

Entities:  

Keywords:  Alternative splicing; AnkyrinG; Axon initial segment; Elavl3; Neuronal polarity; RNA binding protein

Mesh:

Substances:

Year:  2018        PMID: 29614249     DOI: 10.1016/j.neures.2018.03.008

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  2 in total

1.  Nuclear depletion of RNA-binding protein ELAVL3 (HuC) in sporadic and familial amyotrophic lateral sclerosis.

Authors:  Sandra Diaz-Garcia; Vivian I Ko; Sonia Vazquez-Sanchez; Ruth Chia; Olubankole Aladesuyi Arogundade; Maria J Rodriguez; Bryan J Traynor; Don Cleveland; John Ravits
Journal:  Acta Neuropathol       Date:  2021-10-07       Impact factor: 17.088

2.  A Perspective on the Role of Dynamic Alternative RNA Splicing in the Development, Specification, and Function of Axon Initial Segment.

Authors:  Takatoshi Iijima; Takeshi Yoshimura
Journal:  Front Mol Neurosci       Date:  2019-12-05       Impact factor: 5.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.